Growth Metrics

Innoviva (INVA) Amortization of Deferred Charges (2013 - 2026)

Innoviva posted quarterly Amortization of Deferred Charges of $364000.0 for Q1 2026, down 32.72% year-on-year from $541000.0 in Q1 2025, and down 76.26% on a QoQ basis from $1.5 million in Q3 2025.

Innoviva (INVA) has 14 years of Amortization of Deferred Charges data on file, last reported at $364000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Amortization of Deferred Charges fell 32.72% year-over-year to $364000.0; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 6.15% YoY), and the FY2025 full-year result was $1.9 million, down 10.57% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $364000.0, down from $1.5 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.6 million in Q3 2024 and bottomed at $364000.0 in Q1 2026.
  • The 5-year median for Amortization of Deferred Charges is $537000.0 (2025), against an average of $815923.1.
  • The widest annual swing landed in 2022, when Amortization of Deferred Charges plunged 82.95%; it then surged 38.73% in 2023.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $1.5 million in 2022, then rose by 3.89% to $1.5 million in 2023, then increased by 2.07% to $1.6 million in 2024, then decreased by 3.04% to $1.5 million in 2025, then slumped by 76.26% to $364000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $364000.0 (Q1 2026), $1.5 million (Q3 2025), and $537000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 364,000.00
Mar 31, 2026 364,000.00
Sep 30, 2025 1.53 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 537,000.00
Jun 30, 2025 537,000.00
Mar 31, 2025 541,000.00
Mar 31, 2025 541,000.00
Sep 30, 2024 1.58 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 523,000.00
Jun 30, 2024 523,000.00
Mar 31, 2024 525,000.00
Mar 31, 2024 525,000.00
Sep 30, 2023 1.55 Mn
Sep 30, 2023 1.55 Mn
Jun 30, 2023 509,000.00
Jun 30, 2023 509,000.00
Mar 31, 2023 523,000.00
Mar 31, 2023 523,000.00
Sep 30, 2022 1.49 Mn
Sep 30, 2022 1.49 Mn
Jun 30, 2022 554,000.00
Jun 30, 2022 554,000.00
Mar 31, 2022 377,000.00
Mar 31, 2022 377,000.00
Sep 30, 2021 6.78 Mn
Sep 30, 2021 6.78 Mn
Jun 30, 2021 2.26 Mn
Jun 30, 2021 2.26 Mn
Mar 31, 2021 2.21 Mn
Mar 31, 2021 2.21 Mn
Dec 31, 2020 2.17 Mn
Dec 31, 2020 2.17 Mn
Sep 30, 2020 2.12 Mn
Sep 30, 2020 2.12 Mn
Jun 30, 2020 2.08 Mn
Jun 30, 2020 2.08 Mn
Mar 31, 2020 2.03 Mn
Mar 31, 2020 2.03 Mn
Dec 31, 2019 2.01 Mn
Dec 31, 2019 2.01 Mn
Sep 30, 2019 1.97 Mn
Sep 30, 2019 1.97 Mn
Jun 30, 2019 1.93 Mn
Jun 30, 2019 1.93 Mn
Mar 31, 2019 1.89 Mn
Mar 31, 2019 1.89 Mn
Dec 31, 2018 1.85 Mn
Dec 31, 2018 1.85 Mn
Sep 30, 2018 1.87 Mn
Sep 30, 2018 1.87 Mn
Jun 30, 2018 1.94 Mn
Jun 30, 2018 1.94 Mn
Mar 31, 2018 2.09 Mn
Mar 31, 2018 2.09 Mn
Dec 31, 2017 2.16 Mn
Dec 31, 2017 2.16 Mn
Sep 30, 2017 1.55 Mn
Sep 30, 2017 1.55 Mn
Jun 30, 2017 714,000.00
Jun 30, 2017 714,000.00
Mar 31, 2017 687,000.00
Mar 31, 2017 687,000.00
Dec 31, 2016 709,000.00
Dec 31, 2016 709,000.00
Sep 30, 2016 724,000.00
Sep 30, 2016 724,000.00
Jun 30, 2016 715,000.00
Jun 30, 2016 715,000.00
Mar 31, 2016 699,000.00
Mar 31, 2016 699,000.00
Dec 31, 2015 647,000.00
Dec 31, 2015 647,000.00
Sep 30, 2015 769,000.00
Sep 30, 2015 769,000.00
Jun 30, 2015 763,000.00
Jun 30, 2015 763,000.00
Mar 31, 2015 764,000.00
Mar 31, 2015 764,000.00
Dec 31, 2014 858,000.00
Dec 31, 2014 858,000.00
Sep 30, 2014 1.55 Mn
Sep 30, 2014 1.55 Mn
Dec 31, 2013 159,000.00
Dec 31, 2013 159,000.00